Market Overview

Goldman Says FDA Response to Energy Drink Safety Review 'Encouraging' for Monster

Related MNST
Monster Beverage Corp Looks To Squash Subpoenas
Top 4 Stocks In The Beverages-Soft Drinks Industry With The Highest Gross Margin

Commenting on the action in Monster Beverage this afternoon, Goldman Sachs analyst Judy Hong called the FDA's response to the energy drink safety issue "generally benign." Hong believes this should be encouraging for Monster. The analyst believes the most likely outcome related to Durbin's energy drink review will be strong labeling, something which is unlikely to have a material impact on Monster.

Latest Ratings for MNST

DateFirmActionFromTo
Sep 2014Cowen & CompanyInitiates Coverage onMarket Perform
Aug 2014SunTrust Robinson HumphreyDowngradesBuyNeutral
Aug 2014Goldman SachsMaintainsBuy

View More Analyst Ratings for MNST
View the Latest Analyst Ratings

Posted-In: Analyst Color Analyst Ratings Movers

 

Related Articles (MNST)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters